CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock Issued	Additional Paid - In Capital	Treasury Stock	Accumulated Deficit
Balance beginning of period (in shares) at Dec. 31, 2022		113,705,447
Balance, beginning of period at Dec. 31, 2022	$ (17,988)	$ 114	$ 173,804	$ 0	$ (191,906)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022				0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	8,405		8,405
Exercise of stock options (in shares)		4,334
Exercise of stock options	20		20
Employee stock purchase plan (in shares)		235,419
Employee stock purchase plan	680		680
Issuance of restricted stock (in shares)		2,163,925		(62,255)
Issuance of restricted stock	0	$ 2	(195)	$ 193
Restricted stock shares canceled/forfeited	0		193	$ (193)
Restricted stock canceled/forfeited (in shares)				62,255
Net income (loss)	(3,783)				(3,783)
Balance end of period (in shares) at Jun. 30, 2023		116,109,125
Balance, end of period at Jun. 30, 2023	(12,666)	$ 116	182,907	$ 0	(195,689)
Treasury stock, ending balance (in shares) at Jun. 30, 2023				0
Balance beginning of period (in shares) at Mar. 31, 2023		115,380,542
Balance, beginning of period at Mar. 31, 2023	(17,946)	$ 115	178,829	$ (1)	(196,889)
Treasury stock, beginning balance (in shares) at Mar. 31, 2023				334
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	4,060		4,060
Exercise of stock options (in shares)		4,334
Exercise of stock options	20		20
Issuance of restricted stock (in shares)		724,249		(4,485)
Issuance of restricted stock	0	$ 1	(16)	$ 15
Restricted stock shares canceled/forfeited	0		14	$ (14)
Restricted stock canceled/forfeited (in shares)				4,151
Net income (loss)	1,200				1,200
Balance end of period (in shares) at Jun. 30, 2023		116,109,125
Balance, end of period at Jun. 30, 2023	$ (12,666)	$ 116	182,907	$ 0	(195,689)
Treasury stock, ending balance (in shares) at Jun. 30, 2023				0
Balance beginning of period (in shares) at Dec. 31, 2023	146,227,639	146,227,639
Balance, beginning of period at Dec. 31, 2023	$ 142,717	$ 146	276,249	$ 0	(133,678)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023				0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	8,431		8,431
Exercise of stock options (in shares)		146,020
Exercise of stock options	1,010		1,010
Employee stock purchase plan (in shares)		121,783
Employee stock purchase plan	797		797
Issuance of restricted stock, net	(2,501)	$ 2	(2,503)
Issuance of restricted stock, net (in shares)		1,453,960
Shares received in settlement of litigation (in shares)		(1,200,000)
Shares received in settlement of litigation	(9,300)	$ (1)	(9,299)
Net income (loss)	$ 26,886				26,886
Balance end of period (in shares) at Jun. 30, 2024	146,749,402	146,749,402
Balance, end of period at Jun. 30, 2024	$ 168,040	$ 147	274,685	$ 0	(106,792)
Treasury stock, ending balance (in shares) at Jun. 30, 2024				0
Balance beginning of period (in shares) at Mar. 31, 2024		147,528,596
Balance, beginning of period at Mar. 31, 2024	155,731	$ 148	280,000	$ 0	(124,417)
Treasury stock, beginning balance (in shares) at Mar. 31, 2024				0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	4,091		4,091
Exercise of stock options (in shares)		36,100
Exercise of stock options	244		244
Issuance of restricted stock, net			(351)
Issuance of restricted stock, net (in shares)		384,706
Shares received in settlement of litigation (in shares)		(1,200,000)
Shares received in settlement of litigation	(9,300)	$ (1)	(9,299)
Net income (loss)	$ 17,625				17,625
Balance end of period (in shares) at Jun. 30, 2024	146,749,402	146,749,402
Balance, end of period at Jun. 30, 2024	$ 168,040	$ 147	$ 274,685	$ 0	$ (106,792)
Treasury stock, ending balance (in shares) at Jun. 30, 2024				0